Over the past decade, artificial intelligence (AI) and automation have reshaped clinical research. From identifying drug ...

How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

KPL-387 is an independently developed monoclonal antibody that binds human interleukin-1 receptor 1 (IL-1R1), inhibiting the signaling activity of the cytokines interleukin-1α (IL-1α) and ...

The dose-focusing portion of the trial will enroll up to approximately 80 participants with recurrent pericarditis randomized in a 1:1:1:1 ratio to receive KPL-387 300 mg SC biweekly, 300 mg SC ...

A breakthrough clinical trial in Japan reveals that a vitamin B3 derivative significantly improves symptoms of the rare ...

The Phase 2/3 clinical trial design is supported by data from the Phase 1 first-in-human single ascending dose study. Presentation Information ...

A new gene therapy trial safely restores hearing in deaf children and adults, offering hope for those with DFNB9 deafness ...

Thiogenesis Therapeutics, Inc. (TSXV: TTI) (OTCQX: TTIPF), a clinical-stage biopharmaceutical company developing next-generation thiol-based therapies for mitochondrial disease and pediatric metabolic ...

The goal is to test whether the chip, created by Neuralink, a company co-founded by Musk, can give people who are paralysed the ability to use their mind to control computers, smartphones and other ...